These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Decreased activities of lipoprotein lipase and hepatic triglyceride lipase in patients with gout. Tsutsumi Z; Yamamoto T; Moriwaki Y; Takahashi S; Hada T Metabolism; 2001 Aug; 50(8):952-4. PubMed ID: 11474484 [TBL] [Abstract][Full Text] [Related]
23. Reduced hepatic triglyceride secretion in rats fed docosahexaenoic acid-rich fish oil suppresses postprandial hypertriglyceridemia. Ikeda I; Kumamaru J; Nakatani N; Sakono M; Murota I; Imaizumi K J Nutr; 2001 Apr; 131(4):1159-64. PubMed ID: 11285319 [TBL] [Abstract][Full Text] [Related]
24. Transient chylomicronemia preceding the onset of insulin-dependent diabetes in a young girl with no humoral markers of islet autoimmunity. Barbagallo CM; Averna MR; Citarrella R; Rizzo M; Amato M; Noto D; Pugliese A; Cefalù AB; Galluzzo A; Giordano C Eur J Endocrinol; 2004 Jun; 150(6):831-6. PubMed ID: 15191354 [TBL] [Abstract][Full Text] [Related]
25. The clinical, biochemical, and familial presentation of type V hyperlipoproteinemia in childhood. Kwiterovich PO; Farah JR; Brown WV; Bachorik PS; Baylin SB; Neill CA Pediatrics; 1977 Apr; 59(4):513-25. PubMed ID: 191790 [TBL] [Abstract][Full Text] [Related]
26. [Hypertriglyceridemia in a deficiency of lipoprotein lipase and hepatic lipase]. Ikeda Y; Takagi A Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):783-90. PubMed ID: 3270893 [No Abstract] [Full Text] [Related]
31. GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia. Hu X; Dallinga-Thie GM; Hovingh GK; Chang SY; Sandoval NP; Dang TLP; Fukamachi I; Miyashita K; Nakajima K; Murakami M; Fong LG; Ploug M; Young SG; Beigneux AP J Clin Lipidol; 2017; 11(4):964-971. PubMed ID: 28666713 [TBL] [Abstract][Full Text] [Related]
32. Effect of lipoprotein lipase and hepatic triglyceride lipase activity on the distribution of apolipoprotein E among the plasma lipoproteins. Gibson JC; Brown WV Atherosclerosis; 1988 Sep; 73(1):45-55. PubMed ID: 3178931 [TBL] [Abstract][Full Text] [Related]
33. Highly efficacious, long-term, triglyceride lowering with rituximab therapy in a patient with autoimmune hypertriglyceridemia. Béliard S; Di Filippo M; Kaplanski G; Valéro R J Clin Lipidol; 2018; 12(4):883-887. PubMed ID: 29784574 [TBL] [Abstract][Full Text] [Related]
34. Combined lipase deficiency (cld): a lethal mutation on chromosome 17 of the mouse. Paterniti JR; Brown WV; Ginsberg HN; Artzt K Science; 1983 Jul; 221(4606):167-9. PubMed ID: 6857276 [TBL] [Abstract][Full Text] [Related]
35. Gene-environment interaction in the conversion of a mild-to-severe phenotype in a patient homozygous for a Ser172-->Cys mutation in the lipoprotein lipase gene. Ma Y; Liu MS; Ginzinger D; Frohlich J; Brunzell JD; Hayden MR J Clin Invest; 1993 May; 91(5):1953-8. PubMed ID: 8486765 [TBL] [Abstract][Full Text] [Related]
36. Autoimmune severe hypertriglyceridemia induced by anti-apolipoprotein C-II antibody. Yamamoto H; Tanaka M; Yoshiga S; Funahashi T; Shimomura I; Kihara S J Clin Endocrinol Metab; 2014 May; 99(5):1525-30. PubMed ID: 24606081 [TBL] [Abstract][Full Text] [Related]
37. Prevalence and function of anti-lipoprotein lipase auto-antibodies in type V hyperchylomicronemia. Moret M; Pruneta-Deloche V; Sassolas A; Marcais C; Moulin P Atherosclerosis; 2010 Feb; 208(2):324-7. PubMed ID: 19695572 [TBL] [Abstract][Full Text] [Related]